Schwarz Pharma moves into OTC/vitamin area with Central Pharmaceuticals acquisition.
This article was originally published in The Tan Sheet
Executive Summary
SCHWARZ PHARMA ENTERING U.S. OTC/VITAMIN MARKET WITH PURCHASE OF CENTRAL Pharmaceutical, a privately held branded generic and contract manufacturer based in Seymour, Ind. Milwaukee-based Schwarz Pharma Kremers Urban, a wholly-owned subsidiary of Germany's Schwarz Pharma AG, announced on June 7 it had entered into a merger agreement with Central Pharmaceuticals that provides for the purchase of all outstanding Central stock for $177.5 mil.